Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 85, Issue S1, 2015, Pages 724-733

  Lai, Hong Mei ^a,b,c   Xu, Rui ^a,c   Yang, Yi Ning ^a,c   Ma, Yi Tong ^a,c   Li, Xiao Mei ^a,c   Zhao, Qian ^a   Chen, Qing Jie ^a,c   Zhai, Hui ^a,c   Liu, Fen ^a,c   Chen, Bang Dang ^a,c  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b TCM hospital of Xinjiang Uygur Autonomous Region   (China)

^c Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

mean platelet volume; mortality; percutaneous coronary intervention; ST segment elevation myocardial infarction; thrombus burden

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR EQUIPMENT; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL TIME; THROMBOCYTE VOLUME; THROMBUS ASPIRATION; TREATMENT RESPONSE; ADVERSE EFFECTS; AGED; AREA UNDER THE CURVE; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84925259835     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25860     Document Type: Article

References (41)

1. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226-235.
2. Stone PH, Saito S, Takahashi S, Makita Y, Nakamura S, Kawasaki T, Takahashi A, Katsuki T, Nakamura S, Namiki A, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: The PREDICTION study. Circulation 2012; 126: 172-181.
3. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW,. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007; 50: 573-583.
4. Napodano M, Ramondo A, Tarantini G, Peluso D, Compagno S, Fraccaro C, Frigo AC, Razzolini R, Iliceto S,. Predictors and time-related impact of distal embolization during primary angioplasty. Eur Heart J 2009; 30: 305-313.
5. De Luca G, Navarese E, Marino P,. Risk profile and benefits from gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: A meta-regression analysis of randomized trials. Eur Heart J 2009; 30: 2705-2713.
6. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F,. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A meta-analysis of randomized trials. Eur Heart J 2008; 29: 3002-3010.
7. Dudek D, Mielecki W, Burzotta F, Gasior M, Witkowski A, Horvath IG, Legutko J, Ochala A, Rubartelli P, Wojdyla RM, et al. Thrombus aspiration followed by direct stenting: A novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial). Am Heart J 2010; 160: 966-972.
8. Ellis SG, Roubin GS, King SB, Douglas JS, Weintraub WS, Thomas RG, Cox WR,. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372-379.
9. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK,. Incidence and consequences of periprocedural occlusion. The 1985-1986 national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry. Circulation 1990; 82: 739-750.
10. de Feyter PJ, van den Brand M, Laarman GJ, van Domburg R, Serruys PW, Suryapranata H, Jaarman G., Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up [published erratum appears in Circulation 1991;84:446]. Circulation 1991; 83: 927-936.
11. Martin JF, Trowbridge EA, Salmon G, Plumb J,. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443-460.
12. Giles H, Smith RE, Martin JF,. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994; 24: 69-72.
13. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G,. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 46: 284-290.
14. Sarli B, Baktir AO, Saglam H, Arinc H, Kurtul S, Sivgin S, Akpek M, Kaya MG,. Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction. Coron Artery Dis 2013; 24: 285-289.
15. Sianos G, Papafaklis MI, Serruys PW,. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 2010; 22 (10, Suppl B): 6B-14B.
16. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ,. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow phenomenon. Chest 2002; 122: 1322-1332.
17. Napodano M, Peluso D, Marra MP, Frigo AC, Tarantini G, Buja P, Gasparetto V, Fraccaro C, Isabella G, Razzolini R, et al. Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. JACC Cardiovasc Interv 2012; 5: 1170-1177.
18. Ganz W,. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985; 313: 1018
19. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F,. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle myocardial infarction study Group. Circulation 1998; 97: 2302-2306.
20. Napodano M, Dariol G, Al Mamary AH, Marra MP, Tarantini G, D'Amico G, Frigo AC, Buja P, Razzolini R, Iliceto S,. Thrombus burden and myocardial damage during primary percutaneous coronary intervention. Am J Cardiol 2014; 113: 1449-1456.
21. Singh M, Berger PB, Ting HH, Rihal CS, Wilson SH, Lennon RJ, Reeder GS, Bresnahan JF, Holmes DRJ,. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the mayo clinic experience). Am J Cardiol 2001; 88: 1091-1096.
22. Davies MJ,. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82 (3 Suppl): II38-II46.
23. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A,. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1420-1426.
24. Sezer M, Okcular I, Goren T, Oflaz H, Nisanci Y, Umman B, Mercanoglu F, Bilge AK, Meric M, Umman S,. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart 2007; 93: 313-318.
25. Kario K, Matsuo T, Nakao K,. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281-287.
26. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G,. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
27. Hekimsoy Z, Payzin B, Ornek T, Kandogan G,. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 2004; 18: 173-176.
28. Coban E, Afacan B,. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 2008; 19: 111-114.
29. Nechita A, Delcea C, Enache V, Ploesteanu RL, Cazacu C, Andronescu AM, Stroi AM, Stamate CS,. Metabolic syndrome and mean platelet volume variation in patients with chest pain and negative cardiac enzymes. J Med Life 2013; 6: 156-160.
30. Pizzulli L, Yang A, Martin JF, Luderitz B,. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80-84.
31. Khode V, Sindhur J, Kanbur D, Ruikar K, Nallulwar S,. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res 2012; 3: 272-275.
32. Nadar S, Blann AD, Lip GY,. Platelet morphology and plasma indices of platelet activation in essential hypertension: Effects of amlodipine-based antihypertensive therapy. Ann Med 2004; 36: 552-557.
33. Sahin DY, Gur M, Elbasan Z, Yildirim A, Akilli RE, Koyunsever NY, Ozaltun B, Gozubuyuk G, Kivrak A, Cayli M,. Mean platelet volume associated with aortic distensibility, chronic inflammation, and diabetes in patients with stable coronary artery disease. Clin Appl Thromb Hemost 2014; 20: 416-421.
34. Ekici B, Erkan AF, Alhan A, Sayin I, Ayli M, Tore HF,. Is mean platelet volume associated with the angiographic severity of coronary artery disease? Kardiol Polym 2013; 71: 832-838.
35. Kurisu S, Watanabe N, Ikenaga H, Shimonaga T, Higaki T, Iwasaki T, Mitsuba N, Ishibashi K, Dohi Y, Kihara Y,. Increased mean platelet volume in patients with coronary artery disease and its seasonal variation. Int J Cardiol 2014; 172: e159-e161.
36. Martin JF, Bath PM, Burr ML,. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
37. Goncalves SC, Labinaz M, Le May M, Glover C, Froeschl M, Marquis JF, O'Brien E, Shukla D, Ruchin P, Sookur D, et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol 2011; 107: 204-209.
38. Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D,. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 1985; 105: 271-276.
39. Kamath S, Blann AD, Lip GY,. Platelet activation: Assessment and quantification. Eur Heart J 2001; 22: 1561-1571.
40. Haver VM, Gear AR,. Functional fractionation of platelets. J Lab Clin Med 1981; 97: 187-204.
41. Martyn CN, Matthews DM, Popp-Snijders C, Tucker J, Ewing DJ, Clarke BF,. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes. Diabetes Care 1986; 9: 36-39.